These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3885861

  • 1. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
    Nanjo M, Saito M, Aonuma E, Fujimura H, Nakamura T, Aso H, Yoshie O, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
    [Abstract] [Full Text] [Related]

  • 2. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 3. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes.
    Fujii Y, Kimura S, Arai S, Sendo F.
    Cancer Res; 1987 Nov 15; 47(22):6000-5. PubMed ID: 3117360
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T, Shishido K, Murata K.
    Gan To Kagaku Ryoho; 1990 Jul 15; 17(7):1345-50. PubMed ID: 2369138
    [Abstract] [Full Text] [Related]

  • 5. [Antitumor effect of Cepharanthin in the double grafted tumor system].
    Ebina T, Ishikawa K, Murata K.
    Gan To Kagaku Ryoho; 1990 Jun 15; 17(6):1165-71. PubMed ID: 2350192
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 7. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 15; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y, Shimizu K, Okamoto Y, Matsui Y, Ushio Y, Hayakawa T, Tsuda N, Mogami H.
    Gan To Kagaku Ryoho; 1986 Jun 15; 13(6):2082-8. PubMed ID: 3717955
    [Abstract] [Full Text] [Related]

  • 9. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun 15; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 10. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432.
    Saito M, Nanjo M, Aonuma E, Noda T, Nakadate I, Ebina T, Ishida N.
    Int J Cancer; 1984 Feb 15; 33(2):271-6. PubMed ID: 6420351
    [Abstract] [Full Text] [Related]

  • 11. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H, Naito K, Maeda Y, Kobayashi M, Kurioka H, Fujimori C, Tanaka T, Hashimoto I.
    Gan To Kagaku Ryoho; 1983 Jul 15; 10(7):1670-8. PubMed ID: 6870309
    [Abstract] [Full Text] [Related]

  • 12. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N, Saito M, Nanjo M.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [Abstract] [Full Text] [Related]

  • 13. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
    Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F.
    Nat Immun; 1993 Dec 15; 12(2):104-12. PubMed ID: 8318815
    [Abstract] [Full Text] [Related]

  • 14. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
    Mizushima Y, Iwata M, Sato M, Hirata H, Takashima A, Yano S.
    Gan To Kagaku Ryoho; 1986 Jul 15; 13(7):2404-10. PubMed ID: 3729493
    [Abstract] [Full Text] [Related]

  • 15. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y, Hirata H, Sakamoto K, Sato M, Morikage T, Maruyama M, Sasaki K, Yano S.
    Gan To Kagaku Ryoho; 1987 Sep 15; 14(9):2710-5. PubMed ID: 3631971
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
    Ozaki S, Suginoshita T, Watanabe T, Obayashi H.
    Cancer Res; 1990 Aug 01; 50(15):4630-4. PubMed ID: 2369739
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr 01; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov 01; 79(5):1019-24. PubMed ID: 3500354
    [Abstract] [Full Text] [Related]

  • 20. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay.
    de Lapeyrière O, Imbert J, Cot E, Meyer G.
    Bull Cancer; 1981 Nov 01; 68(2):101-8. PubMed ID: 6263382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.